Ellen Moore

2.3k citations

48 papers · 1.6k indexed · h-index 23

Impact in

Immunology top 5%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- Immune cells in cancer
Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research

Papers in ⓘ

Immunology 23
- Immunotherapy and Immune Responses 8
- Immune Cell Function and Interaction 5
- Immune cells in cancer 4
Virology 5
- HIV Research and Treatment 5

Co-authors: Clint Allen (14 shared papers)Carter Van Waes (11 shared papers)Paúl E. Clavijo (8 shared papers)Jay Friedman (10 shared papers)Ruth J. Davis (4 shared papers)Harrison Cash (5 shared papers)James W. Hodge (5 shared papers)Lillian Sun (6 shared papers)
Journals: Cancer Immunology Research (4 papers)The Journal of Pediatrics (3 papers)OncoImmunology (3 papers)Pediatric Research (3 papers)Clinical Cancer Research (2 papers)
Partner nations: United States Sweden United Kingdom

In The Last Decade

Ellen Moore

45 papers receiving 1.6k citations

Peers

Countries citing papers authored by Ellen Moore

Since Specialization

Citations

This map shows the geographic impact of Ellen Moore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ellen Moore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ellen Moore more than expected).

Fields of papers citing papers by Ellen Moore

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ellen Moore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ellen Moore. The network helps show where Ellen Moore may publish in the future.

Co-authors

The 25 scholars most cited alongside Ellen Moore, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ellen Moore Line = papers co-authored together Ellen Moore links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Anti-PD-L1 Efficacy Can Be Enhanced by Inhibition of Myeloid-Derived Suppressor Cells with a Selective Inhibitor of PI3Kδ/γ Cancer Research ·Ruth J. Davis, Ellen Moore, Paúl E. Clavijo, Jay Friedman, Harrison Cash, Zhong Chen, Chris Silvin, Carter Van Waes, Clint Allen	2017	178
2	Cisplatin Alters Antitumor Immunity and Synergizes with PD-1/PD-L1 Inhibition in Head and Neck Squamous Cell Carcinoma Cancer Immunology Research ·Linda Tran, Clint Allen, Roy Xiao, Ellen Moore, Ruth J. Davis, So Jin Park, Katie Spielbauer, Carter Van Waes, Nicole C. Schmitt	2017	146
3	Aberrant Neutrophil Trafficking and Metabolic Oscillations in Severe Pyoderma Gangrenosum Journal of Investigative Dermatology ·Yoshiyuki Adachi, Andrei L. Kindzelskii, Gail Cookingham, Stephen Shaya, Ellen Moore, Robert F. Todd, Howard R. Petty	1998	129
4	Established T Cell–Inflamed Tumors Rejected after Adaptive Resistance Was Reversed by Combination STING Activation and PD-1 Pathway Blockade Cancer Immunology Research ·Ellen Moore, Paúl E. Clavijo, Ruth J. Davis, Harrison Cash, Carter Van Waes, Young Kim, Clint Allen	2016	123
5	PD-1 blockade reverses adaptive immune resistance induced by high-dose hypofractionated but not low-dose daily fractionated radiation OncoImmunology ·Megan V. Morisada, Paúl E. Clavijo, Ellen Moore, Lillian Sun, Michael M. Chamberlin, Carter Van Waes, James W. Hodge, James B. Mitchell, Jay Friedman, Clint Allen	2017	106
6	Enhanced Tumor Control with Combination mTOR and PD-L1 Inhibition in Syngeneic Oral Cavity Cancers Cancer Immunology Research ·Ellen Moore, Harrison Cash, Andria M. Caruso, Ravindra Uppaluri, James W. Hodge, Carter Van Waes, Clint Allen	2016	81
7	Resistance to CTLA-4 checkpoint inhibition reversed through selective elimination of granulocytic myeloid cells Oncotarget ·Paúl E. Clavijo, Ellen Moore, Jianhong Chen, Ruth J. Davis, Jay Friedman, Young Kim, Carter Van Waes, Zhong Chen, Clint Allen	2017	73
8	GRAFT-VERSUS-HOST-DISEASE-ASSOCIATED THYMIC DAMAGE RESULTS IN THE APPEARANCE OF T CELL CLONES WITH ANTI-HOST REACTIVITY1 Transplantation ·Marcel R.M. van den Brink, Ellen Moore, James L.M. Ferrara, Steven J. Burakoff	2000	64
9	Alteration in the Gene Encoding Protein Tyrosine Phosphatase Nonreceptor Type 6 (PTPN6/SHP1) May Contribute to Neutrophilic Dermatoses American Journal Of Pathology ·Andrew B. Nesterovitch, Zsuzsa Györfy, Mark D. Hoffman, Ellen Moore, Nada Elbuluk, Beata Tryniszewska, Tibor A. Rauch, Melinda Simon, Sewon Kang, Gary J. Fisher, Katalin Mikecz, Michael D. Tharp, Tibor T. Glant	2011	61
10	Neoadjuvant PD-1 Immune Checkpoint Blockade Reverses Functional Immunodominance among Tumor Antigen–Specific T Cells Clinical Cancer Research ·Jay Friedman, Ellen Moore, Paul Zolkind, Yvette Robbins, Paúl E. Clavijo, Lillian Sun, Sarah Greene, Megan V. Morisada, Wojciech K. Mydlarz, Nicole C. Schmitt, James W. Hodge, Hans Schreiber, Carter Van Waes, Ravindra Uppaluri, Clint Allen	2019	57
11	Intralesional Injection of Rose Bengal Induces a Systemic Tumor-Specific Immune Response in Murine Models of Melanoma and Breast Cancer PLoS ONE ·Paul Toomey, Krithika N. Kodumudi, Amy Weber, Lisa Kühn, Ellen Moore, Amod A. Sarnaik, Shari Pilon‐Thomas	2013	54
12	Fas-Deficient lpr Mice Are More Susceptible to Graft-Versus-Host Disease The Journal of Immunology ·Marcel R.M. van den Brink, Ellen Moore, Kirsten J. Horndasch, James M. Crawford, J. Hoffman, George F. Murphy, Steven J. Burakoff	2000	53
13	WEE1 kinase inhibition reverses G2/M cell cycle checkpoint activation to sensitize cancer cells to immunotherapy OncoImmunology ·Lillian Sun, Ellen Moore, Rose Berman, Paúl E. Clavijo, Anthony D. Saleh, Zhong Chen, Carter Van Waes, John Davies, Jay Friedman, Clint Allen	2018	46
14	Inhibition of WEE1 kinase and cell cycle checkpoint activation sensitizes head and neck cancers to natural killer cell therapies Journal for ImmunoTherapy of Cancer ·Jay Friedman, Megan V. Morisada, Lillian Sun, Ellen Moore, Michelle R. Padget, James W. Hodge, Jeffrey Schlom, Sofia R. Gameiro, Clint Allen	2018	43
15	Semaphorin4D Inhibition Improves Response to Immune-Checkpoint Blockade via Attenuation of MDSC Recruitment and Function Cancer Immunology Research ·Paúl E. Clavijo, Jay Friedman, Yvette Robbins, Ellen Moore, Ernest Smith, Maurice Zauderer, Elizabeth E. Evans, Clint Allen	2018	40
16	Head growth in sick premature infants—a longitudinal study The Journal of Pediatrics ·Keith H. Marks, M. Jeffrey Maisels, Ellen Moore, Kathleen Gifford, Zvi Friedman	1979	40
17	mTOR and MEK1/2 inhibition differentially modulate tumor growth and the immune microenvironment in syngeneic models of oral cavity cancer Oncotarget ·Harrison Cash, Sujay Shah, Ellen Moore, Andria M. Caruso, Ravindra Uppaluri, Carter Van Waes, Clint Allen	2015	39
18	Aberrant Integrin (CR4;αxβ2; CD11c/CD18) Oscillations on Neutrophils in a Mild Form of Pyoderma Gangrenosum Journal of Investigative Dermatology ·Stephen Shaya, Andrei L. Kindzelskii, John Minor, Ellen Moore, Robert F. Todd, Howard R. Petty	1998	31
19	Influence of Pre-adolescent Diet on Quantitative Ultrasound Measurements of the Calcaneus in Young Adult Women Osteoporosis International ·M. C. Wang, Ellen Moore, Patricia B. Crawford, Mark Hudes, Zak I. Sabry, Robert Marcus, Laura K. Bachrach	1999	29
20	Nanocomplex-based TP53 gene therapy promotes anti-tumor immunity through TP53- and STING-dependent mechanisms OncoImmunology ·Ellen Moore, Lillian Sun, Paúl E. Clavijo, Jay Friedman, Joe B. Harford, Anthony D. Saleh, Carter Van Waes, Esther H. Chang, Clint Allen	2017	26

About Ellen Moore

Ellen Moore is a scholar working on Immunology, Virology, Oncology, Hematology and Infectious Diseases, having authored 48 papers that have together received 1.6k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (8 papers), Cancer Immunotherapy and Biomarkers (7 papers), HIV/AIDS Research and Interventions (6 papers), Immune Cell Function and Interaction (5 papers), HIV Research and Treatment (5 papers), Hematopoietic Stem Cell Transplantation (5 papers), Immune cells in cancer (4 papers) and HIV/AIDS drug development and treatment (4 papers). The work is most often cited by research in Immunology (796 citations), Oncology (787 citations), Dermatology (143 citations), Periodontics (70 citations) and Otorhinolaryngology (51 citations). Ellen Moore has collaborated with scholars based in United States, Sweden and United Kingdom. Frequent co-authors include Clint Allen, Carter Van Waes, Paúl E. Clavijo, Jay Friedman, Ruth J. Davis, Harrison Cash, James W. Hodge, Lillian Sun, Marcel R.M. van den Brink and Steven J. Burakoff. Their work appears in journals such as Cancer Immunology Research, The Journal of Pediatrics, OncoImmunology, Pediatric Research and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact